Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership838,233 shares
Latest Disclosed Value $ 5,792,190
Goldman Sachs Group Inc ownership in VM4 / Vanda Pharmaceuticals Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 838,233 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $4,819,840 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 408,342 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 105.28% during the quarter. The current value of the position is $4,409,106 USD.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (VM4) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:VM4 / Vanda Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 838,233 429,891 105.28 5,792 60.84 0.0002
2026-02-10 2025-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 408,342 68,641 20.21 3,602 112.45 0.0004
2025-11-14 2025-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 339,701 -67,030 -16.48 1,695 -11.67 0.0002
2025-08-14 2025-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 406,731 -287,121 -41.38 1,920 -39.73 0.0003
2025-06-27 2025-03-31 13F/A-2 VANDA PHARMACEUTICALS CMN 921659108 693,852 -93,965 -11.93 3,185 -15.61 0.0005
2025-05-16 2025-03-31 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 693,852 -93,965 3,185 0.0001
2025-05-09 2025-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 693,852 -93,965 3,185 0.0001
2025-02-11 2024-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 787,817 27,459 3.61 3,774 5.80 0.0006
2024-11-14 2024-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 760,358 403,812 113.26 3,566 77.06 0.0006
2024-08-13 2024-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 356,546 -148,839 -29.45 2,014 -3.03 0.0003
2024-05-15 2024-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 505,385 44,172 9.58 2,077 6.73 0.0004
2024-05-14 2023-12-31 13F/A-2 VANDA PHARMACEUTICALS CMN 921659108 461,213 -1,211,363 -72.42 1,946 -73.07 0.0004
2024-03-01 2023-12-31 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 461,213 -1,211,363 1,946 0.0003
2024-02-13 2023-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 461,213 -1,211,363 1,946 0.0001
2024-05-15 2023-09-30 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 1,672,576 -430,915 -20.49 7,226 -47.88 0.0015
2023-11-14 2023-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 1,672,576 -430,915 7,226 0.0015
2024-05-14 2023-06-30 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 2,103,491 452,554 27.41 13,862 23.67 0.0030
2023-08-15 2023-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 2,103,491 452,554 13,862 0.0028
2024-05-14 2023-03-31 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 1,650,937 159,703 10.71 11,210 1.72 0.0026
2023-05-11 2023-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 1,650,937 159,703 11,210 0.0024
2024-05-14 2022-12-31 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 1,491,234 -213,680 -12.53 11,020 68,775.00 0.0027
2023-02-13 2022-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 1,491,234 -213,680 11,020 0.0025
2024-05-14 2022-09-30 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 1,704,914 -127,767 -6.97 17 -15.79 0.0043
2022-11-14 2022-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 1,704,914 -127,767 16,844 0.0039
2024-05-14 2022-06-30 13F/A-2 VANDA PHARMACEUTICALS CMN 921659108 1,832,681 -47,819 -2.54 20 -99.91 0.0050
2022-08-18 2022-06-30 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 1,832,681 -47,819 19,976 0.0045
2022-08-15 2022-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 1,832,681 -47,819 19,976 0.0014
2022-05-16 2022-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 1,880,500 179,244 10.54 21,268 -20.32 0.0045
2022-02-17 2021-12-31 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 1,701,256 885,431 108.53 26,693 90.90 0.0053
2022-02-14 2021-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 1,701,256 885,431 26,693 0.0015
2022-01-20 2021-09-30 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 815,825 157,413 23.91 13,983 -1.26 0.0030
2021-11-10 2021-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 815,825 157,413 13,983 0.0030
2021-08-13 2021-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 658,412 112,063 20.51 14,162 72.58 0.0032
2021-05-17 2021-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 546,349 -259,988 -32.24 8,206 -22.56 0.0021
2021-02-12 2020-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 806,337 9,247 1.16 10,596 37.61 0.0027
2020-11-13 2020-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 797,090 277,706 53.47 7,700 29.59 0.0022
2020-08-12 2020-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 519,384 -115,163 -18.15 5,942 -9.61 0.0018
2020-05-15 2020-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 634,547 -36,839 -5.49 6,574 -40.33 0.0023
2020-02-14 2019-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 671,386 -307,731 -31.43 11,018 -15.26 0.0028
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 979,117 325,430 49.78 13,002 41.17 0.0038
2019-08-14 2019-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 653,687 -177,048 -21.31 9,210 -39.75 0.0027
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 830,735 169,200 25.58 15,286 -11.57 0.0046
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 661,535 73,456 12.49 17,286 28.07 0.0055
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 588,079 383,660 187.68 13,497 246.61 0.0035
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 204,419 -25,394 -11.05 3,894 0.57 0.0011
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 229,813 39,955 21.04 3,872 34.16 0.0010
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 189,858 -236,250 -55.44 2,886 -62.17 0.0007
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 426,108 105,018 32.71 7,628 45.77 0.0019
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 321,090 -7,778 -2.37 5,233 13.66 0.0014
2017-05-18 2017-03-31 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 328,868 -144,041 -30.46 4,604 -38.96 0.0012
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 328,868 4,604
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 472,909 -367,253 -43.71 7,542 -46.05 0.0021
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 840,162 492,276 141.50 13,980 259.11 0.0042
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 347,886 34,980 11.18 3,893 48.81 0.0013
2016-05-13 2016-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 312,906 253,644 428.00 2,616 373.91 0.0009
2016-02-16 2015-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 59,262 -77,268 -56.59 552 -64.16 0.0002
2015-11-13 2015-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 136,530 -2,699,956 -95.19 1,540 -95.72 0.0005
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 2,836,486 -1,368,906 -32.55 35,995 -7.96 0.0112
2015-05-15 2015-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 4,205,392 4,026,749 2,254.08 39,110 1,428.93 0.0126
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 178,643 -550,305 -75.49 2,558 -66.19 0.0008
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 728,948 202,477 38.46 7,566 -11.18 0.0024
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 526,471 197,191 59.89 8,518 59.19 0.0027
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS CMN 921659108 329,280 -171,469 -34.24 5,351 -13.89 0.0018
2014-02-14 2013-12-31 13F VANDA PHARMACEUTICALS CMN 921659108 500,749 157,523 45.89 6,214 65.35 0.0020
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS CMN 921659108 343,226 322,274 1,538.15 3,758 2,123.67 0.0014
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS CMN 921659108 20,952 20,952 169 0.0001
2013-06-14 2012-12-31 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 0 -11,347 -100.00 0 -100.00
2013-06-14 2012-09-30 13F/A-2 VANDA PHARMACEUTICALS CMN 921659108 11,347 12 0.11 46 -8.00 0.0000
2013-06-14 2012-06-30 13F/A-2 VANDA PHARMACEUTICALS CMN 921659108 11,335 -9,450 -45.47 50 -50.00 0.0000
2013-06-14 2012-03-31 13F/A-1 VANDA PHARMACEUTICALS CMN 921659108 20,785 20,785 100 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS CMN Call 4,100 -94.41 62 -95.28 n/a n/a n/a
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS CMN Call 73,400 36.69 1,314 50.17 n/a n/a n/a
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS CMN Call 53,700 4,375.00 875 5,047.06 n/a n/a n/a
2017-05-18 2017-03-31 13F/A VANDA PHARMACEUTICALS CMN Call 1,200 -90.91 17 -91.94 n/a n/a n/a
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS CMN Call 1,200 17 n/a n/a n/a
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS CMN Call 13,200 -25.00 211 -27.99 n/a n/a n/a
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS CMN Call 17,600 -82.90 293 -74.54 n/a n/a n/a
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS CMN Call 102,900 10.29 1,151 47.56 n/a n/a n/a
2016-05-13 2016-03-31 13F VANDA PHARMACEUTICALS CMN Call 93,300 -4.11 780 -13.91 n/a n/a n/a
2016-02-16 2015-12-31 13F VANDA PHARMACEUTICALS CMN Call 97,300 800.93 906 642.62 n/a n/a n/a
2015-11-13 2015-09-30 13F VANDA PHARMACEUTICALS CMN Call 10,800 -90.04 122 -91.13 n/a n/a n/a
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS CMN Call 108,400 -40.01 1,376 -18.14 n/a n/a n/a
2015-05-15 2015-03-31 13F VANDA PHARMACEUTICALS CMN Call 180,700 117.71 1,681 41.38 n/a n/a n/a
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS CMN Call 83,000 -5.79 1,189 30.09 n/a n/a n/a
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS CMN Call 88,100 146.78 914 58.13 n/a n/a n/a
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS CMN Call 35,700 -96.55 578 -96.57 n/a n/a n/a
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS CMN Call 1,036,200 124.48 16,838 193.96 n/a n/a n/a
2014-02-14 2013-12-31 13F VANDA PHARMACEUTICALS CMN Call 461,600 -46.75 5,728 -39.66 n/a n/a n/a
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS CMN Call 866,900 315.58 9,493 463.38 n/a n/a n/a
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS CMN Call 208,600 1,685 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS CMN Put 301,200 6,745.45 4,578 5,694.94 n/a n/a n/a
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS CMN Put 4,400 -45.68 79 -40.15 n/a n/a n/a
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS CMN Put 8,100 145.45 132 186.96 n/a n/a n/a
2017-05-18 2017-03-31 13F/A VANDA PHARMACEUTICALS CMN Put 3,300 -99.34 46 -99.43 n/a n/a n/a
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS CMN Put 3,300 46 n/a n/a n/a
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS CMN Put 501,800 -0.26 8,004 -4.40 n/a n/a n/a
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS CMN Put 503,100 435.21 8,372 695.82 n/a n/a n/a
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS CMN Put 94,000 0.86 1,052 35.04 n/a n/a n/a
2016-05-13 2016-03-31 13F VANDA PHARMACEUTICALS CMN Put 93,200 -0.75 779 -10.87 n/a n/a n/a
2016-02-16 2015-12-31 13F VANDA PHARMACEUTICALS CMN Put 93,900 -12.49 874 -27.77 n/a n/a n/a
2015-11-13 2015-09-30 13F VANDA PHARMACEUTICALS CMN Put 107,300 7.84 1,210 -4.20 n/a n/a n/a
2015-08-14 2015-06-30 13F VANDA PHARMACEUTICALS CMN Put 99,500 5,136.84 1,263 6,916.67 n/a n/a n/a
2015-05-15 2015-03-31 13F VANDA PHARMACEUTICALS CMN Put 1,900 -84.68 18 -89.89 n/a n/a n/a
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS CMN Put 12,400 121.43 178 206.90 n/a n/a n/a
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS CMN Put 5,600 -97.48 58 -98.38 n/a n/a n/a
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS CMN Put 221,800 32.66 3,589 32.09 n/a n/a n/a
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS CMN Put 167,200 -29.87 2,717 -8.18 n/a n/a n/a
2014-02-14 2013-12-31 13F VANDA PHARMACEUTICALS CMN Put 238,400 -50.44 2,959 -43.82 n/a n/a n/a
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS CMN Put 481,000 5,267 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.